Heartflow, Inc. — Director's Dealing 2026

Feb 10, 2026

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Heartflow, Inc. (HTFL)
CIK: 0001464521
Period of Report: 2026-02-06

Reporting Person: Rogers Campbell (Chief Medical Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2026-02-06	Common Stock	F	515	$27.74	Disposed	20098	Direct
2026-02-06	Common Stock	A	54073	—	Acquired	74171	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2026-02-06	Stock Option	$27.74	A	94488	Acquired	2036-02-06	Common Stock (94488)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22615	Indirect
Common Stock	46159	Indirect
Common Stock	26012	Indirect
Common Stock	50754	Indirect

Footnotes

F1: Represents shares that have been retained by the Issuer to satisfy income tax withholding and remittance obligations in connection with the vesting and net settlement of restricted stock units previously reported.

F2: Represents restricted stock units ("RSUs"), with a vesting commencement date of February 6, 2026 (the "Vesting Commencement Date"). 1/16th of the RSUs vest on each quarterly anniversary of the Vesting Commencement Date,
subject to continued service through the applicable vesting date.

F3: The option vests 1/48 on each monthly anniversary of the Vesting Commencement Date, subject to continued service through the applicable vesting date.